Showing results (5571-5580 of 5,703) with videos related to

Sort By:
Pageof 571
The Oncologist|February 3, 2026
Malnutrition in gastrointestinal cancer manifests before systemic therapy and is associated with fatigue and reduced physical quality of lifeMats L Wiese, Lena Schwarz, Sabrina von Rheinbaben, et al.
The Oncologist|February 6, 2026
Differential life expectancies and life years lost associated with multiple myeloma in the United States: a simulation modelling studyTzeyu L Michaud, Yi-Hsuan Shih, Mengmeng Ji, et al.
The Oncologist|February 15, 2026
A prospective external validation of the GRade, Age, Nodes and Tumor (GRANT) score in the ECOG-ACRIN EA8143 PROSPER trialSebastiano Buti, Se-Eun Kim, Michele Maffezzoli, et al.
The Oncologist|February 15, 2026
Metastatic Breast Cancer Outcome in a Real-World Setting: Analysis for Long-Term Survival and Curability in a Prospective DatasetArlene Chan, Mengdie Zhou, Mridula Arun, et al.
The Oncologist|July 1, 2025
Timing and clinical significance of chemotherapy in patients with resected gastric adenocarcinoma: a population-based cohort studyDi Zhang, Qian Yang, Chunwang Ji, et al.
The Oncologist|July 1, 2025
Trastuzumab plus lapatinib or chemotherapy in patients with HER2-overexpressed advanced breast cancer: a randomized, phase II trial (GIM12-TYPHER)Carmine De Angelis, Martina Pagliuca, Emanuela Magnolfi, et al.
The Oncologist|June 27, 2025
Long-term safety analysis of pooled data for tislelizumab as monotherapy or in combination with chemotherapy in patients with advanced cancersCaicun Zhou, Rose Huang, Yuan Yuan, et al.
The Oncologist|June 14, 2025
Pooled biomarker analysis of the association of baseline T regulatory cells with response and T-cell recovery profiles with blinatumomab treatmentYuliya Katlinskaya, Bharat Panwar, Yi Zeng, et al.
The Oncologist|June 17, 2025
Real-world treatment patterns and outcomes of patients with hormone receptor-positive/HER2-low metastatic breast cancer treated with chemotherapySandhya Mehta, Jackie Kwong, Clara Lam, et al.
The Oncologist|June 17, 2025
COVID-19 burden of illness in people who are immunocompromised due to cancer: an expert opinion reviewIgor Aurer, Paul Moss, Michel Goldman, et al.
Pageof 571